Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal

Published 1 week ago Neutral
Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal
Auto

Related Stocks

NOVO-B.CO Novo Nordisk A/...
The lawsuit says Novo Nordisk’s offer for drug startup Metsera isn’t reasonably likely to be completed.

Continue Reading

View Comments

More News

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial

44 minutes ago Positive

Why Archer Aviation Stock Plummeted This Week

1 hour ago Neutral

Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial

1 hour ago Positive

Is Bilibili’s Recent Pullback a Chance After Digital Media Partnerships?

1 hour ago Positive

JPMorgan Chase-Backed Propel Launches $20M SNAP Relief Fund As Millions Of Families Wait For Food Benefits During Government Shutdown

1 hour ago Neutral